Page last updated: 2024-09-03
8-azidoadenosine-3',5'-monophosphate and acitretin
8-azidoadenosine-3',5'-monophosphate has been researched along with acitretin in 1 studies
Compound Research Comparison
| Studies (8-azidoadenosine-3',5'-monophosphate) | Trials (8-azidoadenosine-3',5'-monophosphate) | Recent Studies (post-2010) (8-azidoadenosine-3',5'-monophosphate) | Studies (acitretin) | Trials (acitretin) | Recent Studies (post-2010) (acitretin) |
|---|---|---|---|---|---|
| 119 | 1 | 1 | 1,328 | 95 | 548 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Anderson, WB; Bouloc, A; Evain-Brion, D; Gerbaud, P; Gorin, I; Raynaud, F | 1 |
Other Studies
1 other study(ies) available for 8-azidoadenosine-3',5'-monophosphate and acitretin
| Article | Year |
|---|---|
Rapid effect of treatment of psoriatic erythrocytes with the synthetic retinoid acitretin to increase 8-azido cyclic AMP binding to the RI regulatory subunit.
Topics: Acitretin; Affinity Labels; Azides; Cell Separation; Cyclic AMP; Dose-Response Relationship, Drug; Erythrocyte Membrane; Erythrocytes; Humans; Protein Kinases; Psoriasis; Time Factors | 1993 |